Serum Prolactin Levels and Mortality in Adults Without Prolactinoma: A Meta-Analysis
Autores da FMUP
Participantes de fora da FMUP
- Papazoglou, Andreas S.
- Moysidis, V, Dimitrios
- Anastasiou, Vasileios
- Daios, Stylianos
- Borges-Canha, Marta
- Giannopoulos, Georgios
- Ziakas, Antonios
- Giannakoulas, George
Unidades de investigação
Abstract
Context Prolactin (PRL) is a highly versatile, multifunctional hormone synthesized and secreted by lactotroph cells of the anterior pituitary. Its metabolic role has been extensively studied even in normoprolactinemic populations. Recently, a wealth of observational data have outlined the potential prognostic value of PRL in various clinical settings.Objective This systematic review aims to systematically evaluate and quantitatively synthesize the association between serum PRL levels and risk of mortality in adults without prolactinoma.Methods A systematic literature search was conducted up to June 10, 2023, to identify studies reporting the association of serum PRL levels with clinical outcomes of adults without prolactinoma. A random-effects meta-analysis was conducted to quantify the adjusted hazard ratios [(a)HRs] for all-cause and cardiovascular death (CVD) during follow-up.Results Twenty-eight studies were deemed eligible reporting the outcomes of adults without prolactinoma, in whom serum PRL levels were measured for risk-stratification. Fourteen studies reported appropriate data for meta-analysis encompassing a total of 23 596 individuals. Each unit of PRL increase was independently associated with increased risk of all-cause (pooled aHR = 1.17 [1.08-1.27]; I2 = 48%) and CV mortality (pooled aHR = 1.54 [1.14-2.09]; I2 = 89%). Individuals belonging to the highest PRL category had significantly higher risk for all-cause (pooled aHR = 1.81 [1.43-2.30]; I2 = 65%) and CV (pooled aHR = 1.59 [1.04-2.42]; I2 = 82%) mortality compared to their lowest-PRL category counterparts. The association between PRL levels and in-hospital death did not reach statistical significance.Conclusion PRL levels seem to be an independent predictor for mortality. Further validation is warranted before its role as a risk-stratification tool can be delineated in clinical practice.
Dados da publicação
- ISSN/ISSNe:
- 0021-972X, 1945-7197
- Tipo:
- Article
- Páginas:
- 1652-1664
- Link para outro recurso:
- www.scopus.com
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM Endocrine Society
Citações Recebidas na Web of Science: 4
Citações Recebidas na Scopus: 4
Documentos
- Não há documentos
Filiações
Keywords
- prolactin; biomarker; cardiovascular risk; cardiovascular death; risk stratification
Campos de estudo
Proyectos asociados
Predictors of readmission and mortality in patients with decompensated heart failure according to glycaemic status
Investigador Principal: João Sérgio de Lima Soares Neves
Estudo Clínico Académico (Glycaemic status) . 2023
Association of Glycemic Variability and Time in Range with Lipid Profile in Type 1 Diabetes
Investigador Principal: João Sérgio de Lima Soares Neves
Estudo Clínico Académico (Glycemic Variability) . 2023
Time in Range and Complications of Diabetes: a Cross-Sectional Analysis of patients with Type 1 Diabetes
Investigador Principal: João Sérgio de Lima Soares Neves
Estudo Clínico Académico (Type 1 Diabetes) . 2023
Evaluation of thyroid function in patients hospitalized for acute heart failure
Investigador Principal: João Sérgio de Lima Soares Neves
Estudo Clínico Académico (Heart failure) . 2021
Predictors Of The Effectiveness Of Insulin Pumps In Patiens With Type 1 Diabetes Mellitus
Investigador Principal: João Sérgio de Lima Soares Neves
Estudo Clínico Académico . 2021
Impacto da pandemia COVID-19 no controlo metabólico de doentes com Diabetes Mellitus Tipo 1
Investigador Principal: João Sérgio de Lima Soares Neves
Estudo Clínico Académico . 2022
Influence of Diabetes on Response to Ultrasound Guided Hydrodistension Treatment of Adhesive Capsulitis: a Retrospective Study
Investigador Principal: João Sérgio de Lima Soares Neves
Estudo Clínico Académico (Hydrodistension ) . 2022
Influence of Cystic Fibrosis-Related Diabetes on the Severity of Cystic Fibrosis Phenotype
Investigador Principal: João Sérgio de Lima Soares Neves
Estudo Clínico Académico . 2022
Citar a publicação
Papazoglou AS,Leite AR,V,,Anastasiou V,Daios S,Borges M,Giannopoulos G,Neves JS,Ziakas A,Giannakoulas G. Serum Prolactin Levels and Mortality in Adults Without Prolactinoma: A Meta-Analysis. J. Clin. Endocrinol. Metab. 2024. 109. (8):p. 1652-1664. IF:5,800. (1).